J Korean Radiol Soc.  1998 Apr;38(4):629-633. 10.3348/jkrs.1998.38.4.629.

Survival Rates in Hepatocellular Carcinoma Patient Treated by Transarterial Chemoembolization: Comparison withOperable and Inoperable Cases

• Moon TY

• KMID: 2201368
• DOI: http://doi.org/10.3348/jkrs.1998.38.4.629

Abstract

PURPOSE: To pr6edict the prognosis of hepatocellular carcinoma (HCC) patients who underwent transarte6rialchemoembolization(TACE).
MATERIALS AND METHODS
The study unvestigated the one- and two-year survival rates of 211patients who were divided into two groups : 74 operable Child's grade A or B cases, and 137 inoperable casesinvolving Child's grade C or poor prognostic factors such as metastasis, main portal thrombus, and total bilirubinabove 2.0mg/dl. Cumulative survival curves were obtained by the Kaplan-Meier method, beginning with the day of thefirst TACE.
RESULTS
The one- and two-year cummulative survival rates were 80.8% and 47.9% for the 74 operablecases and 37.6% and 14.0% for the 137 inoperable cases, respectively(P<0.01).
CONCLUSION
The prognosis of HCCpatients who underwent TACE can be predicted by classifying then into two groups, operable or inoperable cases.

Keyword

Chemotherapeutic infusion; Liver neoplasms, chemotherapeutic infusion; Arteries, therapeutic blockade

MeSH Terms

Carcinoma, Hepatocellular*
Humans
Neoplasm Metastasis
Prognosis
Survival Rate*
Thrombosis